ARCHIVES

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

This article is from The Cancer Letter archive.

Vol. 01 No. 48 | November 28, 1975

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

CAB Reluctantly Approves Use Of Contract To Support Cancer Journals

February 15, 1985

NCI-Approved Clinical Trials

May 30, 2003

Low-Dose Warfarin Prevents Blood Clots, NIH Study Finds

February 28, 2003

NCI begins rewrite of cancer center grant guidelines; will allow clinical investigator support. Goal is to implement P30-P50 working group recommendations, simplify guidelines, Karen Antman tells advisory board.

March 19, 2004

UCSF Wins $500,000 Grant From Bristol-Myers Squibb Foundation

March 15, 2002